US Stock MarketDetailed Quotes

PPBT Purple Biotech

Watchlist
  • 0.554
  • +0.052+10.34%
Close May 17 16:00 ET
  • 0.554
  • 0.0000.00%
Post 19:30 ET
14.47MMarket Cap-615P/E (TTM)

Purple Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Purple Biotech Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.18

+45.45%
Analyst Rating

Buy

Apr 30, 2024

Purple Biotech Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 0.000--
--2024/Q1-- / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2021/Q10.000 / 2.300M--
--2020/Q40.000 / 2.300M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 0.000--
--2024/Q1-- / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2021/Q10.000 / 2.300M--
--2020/Q40.000 / 2.300M--

Unlock Free Earnings Estimates

Purple Biotech Earnings Reports

  • Purple Biotech | 20-F: Registration statement / Annual report / Transition report

    Mar 5 16:06 ET

  • Purple Biotech | 6-K: Report of foreign private issuer (related to financial reporting)

    Mar 5 08:02 ET

  • Purple Biotech | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 21, 2023 07:00 ET

  • Purple Biotech | 6-K: Report of foreign private issuer (related to financial reporting)

    Oct 19, 2023 10:36 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Apr 30, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg
    Concept Top Gainers Yesterday
    Top Gainers Yesterday
    Intraday-2.47%